Harbour Investments Inc. grew its position in Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Free Report) by 43.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,563 shares of the company’s stock after purchasing an additional 2,895 shares during the quarter. Harbour Investments Inc.’s holdings in Amplify Weight Loss Drug & Treatment ETF were worth $256,000 as of its most recent SEC filing.
Amplify Weight Loss Drug & Treatment ETF Stock Down 3.3 %
NYSEARCA:THNR opened at $23.15 on Monday. The business’s 50 day moving average price is $26.22. Amplify Weight Loss Drug & Treatment ETF has a 1-year low of $23.11 and a 1-year high of $28.19.
Further Reading
- Five stocks we like better than Amplify Weight Loss Drug & Treatment ETF
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Upcoming IPO Stock Lockup Period, Explained
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Are Dividend Champions? How to Invest in the Champions
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Amplify Weight Loss Drug & Treatment ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and related companies with MarketBeat.com's FREE daily email newsletter.
